FDA Stops Shipments of 33 Generic Drugs from Caraco Pharmaceutical Laboratories, Ltd. Plants

Bookmark and Share

WASHINGTON, June 25 -- Federal marshals dispatched by the FDA have stopped all shipments from three generic drug manufacturing plants in Michigan operated by Caraco Pharmaceutical Laboratories.

MORE ON THIS TOPIC